195400,74696,{\rtf1\ansi\ansicpg1252\deff0\deflang1033{\fonttbl{\f0\fnil\fcharset0 Times New Roman;}{\f1\froman\fprq2\fcharset0 Times New Roman;}{\f2\fswiss\fprq2\fcharset0 Consolas;}{\f3\fswiss\fprq2\fcharset0 Calibri;}}
{\colortbl ;\red0\green0\blue255;\red40\green40\blue40;\red255\green255\blue255;}
\viewkind4\uc1\pard\sb240\sa160\sl252\slmult1\qc\lang16393\ul\b\f0\fs40 DEPARTMENT OF MEDICAL ONCOLOGY\fs36\par
\pard\nowidctlpar\sa200\sl276\slmult1\qc\lang9\ulnone\fs28\par
TREATMENT SUMMARY\par
\par
\pard\hyphpar0\sa200\sl276\slmult1\qj\kerning2\ul\f1\fs24 FINAL DIAGNOSIS:\line\ulnone\b0 CARCINOMA COLON - \lang16393 PROGRESSIVE DISEASE\lang9\ul\b\line\ulnone\b0 CARCINOMA GASTROESOHAGEAL JUNCTION\lang16393\kerning1\b\par
\pard\hyphpar0\sa160\sl252\slmult1\qj\ul DRUG ALLERGY\ulnone :\line\b0 Not known\b\par
\pard\sa200\sl276\slmult1\qj\ul CHIEF COMPLAINTS\ulnone :\line\lang9\kerning2\b0 Mr. K P Thomas, 71-yrs-old male, \lang3081 case of Carcinoma GE junction and Carcinoma Colon, recurrent disease. \lang16393 He presented with complaints of p\lang3081 erianal irritation\lang16393 , lower abdominal pain and loss of appetite. He also complaints of c\lang3081 ough\lang16393 . Now admitted for furthur evaluation and management. \lang3081  \lang16393\kerning1\b\line\line\ul HISTORY AS FOLLOWS: \ulnone\line\lang9\kerning2\b0 Mr. K P Thomas, 71-yrs-old male, evaluated elsewhere with bleeding per rectum in 1980 and found to have a rectal growth which was resected (wound healing delayed for 2 years, was on homeo medications). HPR reported as Adenocarcinoma. No adjuvant treatment given. \line In 1982, again he developed bleeding per rectum and on evaluation colonic growth detected and resected. HPR reported as Adenocarcinoma. No adjuvant treatment given.\line In 1985, he was found to be anemic and imaging revealed growth at resected site and again resection done. HPR reported as Adenocarcinoma. No adjuvant treatment given. \line He was on regular follow up.\line In 1993, he developed skin lesions over face, which was resected. HPR reported as Squamous cell carcinoma. \line In 1995, Colonoscopy revealed growth at 45 cms. Underwent Subtotal colectomy with ileo-rectal anastomosis on 24/6/1995. HPR reported as moderately differentiated adenocarcinoma (Grade II), Colon. He recevied 2 cycles of chemotherapy with Cisplatin/5Flurouracil. \line Past history of multiple blood transfusions. \line He was on regular follow up.\line Came here on 3/5/2018 at Gastromedicine department with complaints of with c/o \lang3081 mild dysphagia and 4 kg weight loss over past one month. USG abdomen done on 3.5.2018 showed minimal coarsening of parenchymal echotexture of liver. Endoscopy on 5.5.2018 revealed Carcinoma GE junction. Colonoscopy on 5.5.2018 showed ? Carcinoma rectum. CECT abdomen done on 5.5.2018 showed Irregular wall thickening of rectum with polypodal lesion arising from the posterior wall - ? Recurrence. Ill defined lesion with irregular margins in the stomach involving cardia, fundus and upper body ? carcinoma stomach. Few small upper para aortic and para vertebral lymph nodes noted. Right renal cortical cysts - Bosniak type I. Endoscopic biopsy from rectal lesion revealed Moderately differentiated adenocarcinoma. \line\lang16393 Received 10 cycles of chemotherapy with mFOLFOX, last cycle was on 17\lang9 /10/2018\lang16393 .\lang9\line\lang16393 Post \lang3081 6th cycle\lang16393  reassessment \lang3081 CT abdomen revealed mild reduction in stomach as well as rectal thickening and mild reduction in perigastric node.\line\b\f0 CT CHEST AND ABDOMEN PLAIN AND CONTRAST\lang16393  (01/11/2018)\b0\f1  :\lang3081 Mild increase in the size and thickness of the gastric and rectal lesions\lang16393 .\line USG abdomen (29/01/2019) : \lang3081 Mild hepatomegaly. No obvious hepatic focal lesions.\lang16393  \lang3081 Few right simple renal cortical cysts - Bosniak category 1.\lang16393  \lang3081 No ascites\lang16393  \par
\kerning1\ul\b EXAMINATION\ulnone :\b0  \line ECOG PS : 1\line Conscious, oriented\line Vitals stable\line Pallor +\line\lang9\kerning2\fs22 RESPIRATORY SYSTEM: B/L NVBS\line CARDIOVASCULAR SYSTEM: S1S2 +\line ABDOMEN: Soft, non \lang16393 distended\lang9\line CENTRAL NERVOUS SYSTEM: No FND\line\kerning0\par
\pard\qj\ul\b\fs24 INVESTIGATIONS:\line\pard\lang3081\ulnone\f2\fs20 19-02-2019 02:50 PM\b0\line\b Name                                  Result     Unit         Reference\line\b0 Haemoglobin                           7.0       g/dl          13.0 - 17.0         \line TC                                    8.3       x10^3/ul      4.0 - 11.0          \line Differential Count                    SubHead                                     \line Neutrophils                           79        %             40.0 - 80.0         \line Lymphocytes                           14        %             20.0 - 40.0         \line Monocytes                             6         %             2.0 - 10.0          \line Eosinophils                           1         %             1.0 - 6.0           \line Basophils                             0         %             0.0 - 2.0           \line Neutrophils Count                     6.4       x10^3/ul      2.0 - 7.0           \line Lymphocytes Count                     1.2       x10^3/ul      1.0 - 3.0           \line Monocytes Count                       0.5       x10^3/ul      0.2 - 1.0           \line Eosinophils Count                     0.1       x10^3/ul      0.02 - 0.44         \line Basophils Count                       0.0       cells/cumm    0.02 - 0.1          \line RBC Count                             3.1       x10^6/ul      3.8 - 5.3           \line Hct                                   25        %             40.0 - 54.0         \line MCV                                   81        fl            80.0 - 100.0        \line MCH                                   23        pg            27.0 - 32.0         \line MCHC                                  28        g/dl          32.0 - 36.0         \line Platelet                              280       x10^3/ul      150.0 - 450.0       \line RDW                                   20.3      %             10.0 - 16.5         \line MPV                                   8.9       fl            7.5 - 11.5\line\b 19-02-2019 02:50 PM\b0\line\b Name                                  Result     Unit         Reference\line\b0 Renal Function Test                                                               \line Urea                                  27.82     mg/dl         15.00 - 45.00       \line Creatinine                            0.94      mg/dl         0.60 - 1.40\line\line\pard\qj\lang9\kerning2\ul\b\f1\fs24 CHEMOTHERAPY GIVEN:\line\lang16393\kerning1\f0 CYCLE 1 DAY 1 CHEMOTHERAPY (20/02/2019) :\line\ulnone\b0\f1 Inj. RANTAC 50 mg slow IV bolus\line Inj. AVIL 25 mg slow IV bolus\line Tab. DOLO 650 mg PO\line\line Inj. KEYTRUDA (\lang3081 PEMBROLIZUMAB\lang16393 ) 100 mg in 100 ml NS over 30 min\kerning2\ul\b\par
\lang9\kerning0\line COURSE IN THE HOSPITAL:\line\lang16393\kerning1\ulnone\b0 Patient was admitted with above mentioned complaints. Routine blood investigations were normal, except low hemoglobin (7 gm/dl). CECT chest + abdomen on 19/02/2019, suggestive of disease progression. He was given cycle 1 immunotherapy on 20/02/2019 and tolerated it well. He is being discharged in a stable state of health. \line\line\pard\nowidctlpar\sa200\sl276\slmult1\qj\lang9\kerning0\ul\b\f0 DISCUSSION:\par
\ulnone\b0\fs22 The nature of disease, stage of disease, treatment options, and prognosis were discussed with the patient and family.\par
The expected benefits, possible adverse effects (both temporary and permanent) and approximate expenses associated with the planned chemotherapy was discussed with the patient and relatives by Medical Oncology doctors, before an informed consent was taken from the patient.\par
Chemotherapy was tolerated well during this admission by the patient. No significant adverse effects were encountered. Patient was explained about signs and symptoms of possible delayed adverse effects along with the precautions to be practiced while on chemotherapy and was discharged in a stable condition.\ul\b\fs24\par
\pard\sa200\sl276\slmult1\qj\f1 DISCHARGE MEDICATIONS:\line\lang16393\kerning1\ulnone\b0 Tab. LIVOGEN Z 1 tab 1-0-0 on alternate days x 3 weeks\lang9\line\lang16393 Tab. PANTOCID DSR if needed for gastritis\line\line\lang9 Before leaving your hospital bed, please talk to the nursing staff looking after you and ensure that you have the above medications with you and you understand how to take them after discharge from the hospital.\kerning0\ul\b\par
\line FOLLOW UP VISIT INSTRUCTIONS:\line\kerning1\ulnone\b0 Review in Medical oncology OPD on 13/0\lang16393 3\lang9 /2019 with CBC\lang16393 , RFT, SGPT, ALP and RBS\lang9  report\kerning0\fs22\line\pard\nowidctlpar\sa200\sl276\slmult1\qj\f0\line PLEASE MAKE AN APPOINTMENT AND COME TO ONCOLOGY DEPARTMENT with blood test/ scans (if ordered) reports on the above mentioned date.\ul\b\fs24\par
EMERGENCY VISIT INSTRUCTIONS:\par
\ulnone\b0\fs22 In case of emergency or any unexpected problem if you need to see your doctor please report to Rajagiri Emergency department triage with all your medical reports.\par
In event of the following complaints like fever or chills, persistent diarrhoea, vomiting, oral ulcers, difficulty in swallowing, abdominal pain, new skin lesions or bleeding, please report without delay.\ul\b\fs24\par
POST CHEMOTHERAPY INSTRUCTIONS:\par
\ulnone\b0\fs22 1. Ask your doctor any doubts regarding disease and treatment.\par
2. There is no specific diet recommended after chemotherapy.\par
3. Check blood counts in between and SMS your doctor (if requested).\par
4. Do blood investigations prior to next cycle of chemotherapy as requested by your doctor.\par
5. Please inform your regular medications to your doctor.\par
6. Bring day care chemotherapy card with you.\par
7. Avoid over the counter medications/ alternative medicine unless allowed by your doctor.\par
8. If you develop fever more than or equal to \lang16393\fs24 100 F or severe vomiting, tiredness, contact the hospital/ doctor immediately.\par
9. Please have the discharge summary with you when you call your doctor.\par
10. Please note down Emergency numbers:\par
\tab Rajagiri Hospital : 0484- 2905000\line\par
\pard\nowidctlpar\sa200\sl276\slmult1\qc\b "Wish you a speedy recovery"\par
\par
\pard\nowidctlpar\sa200\sl276\slmult1\b0 Name and Signature of Consultant\par
\par
\pard\lang1033\kerning2\b\fs22 Dr. Sanju Cyriac, MD (General Medicine), DM (Medical Oncology), DNB\par
\b0 Consultant - Medical Oncology\tab\tab\tab\tab\line Rajagiri Hospital\par
Phone no: +91 9747880036\tab\line E-Mail: \cf1\ul sanju.cyriac@rajagirihospital.com <mailto:sanju.cyriac@rajagirihospital.com>\cf0\ulnone\fs21\par
\fs22\par
\b Dr. Subi T. S., MS (General surgery AIIMS, DELHI), MCh (Surgical Oncology, TATA, MUMBAI)\par
\b0 Consultant - Surgical Oncology\tab\tab\tab\tab\line Rajagiri Hospital\par
Phone no: +91 8547737149\tab\line E-Mail: \cf1\ul subi.ts@rajagirihospital.com <mailto:subi.ts@rajagirihospital.com>\cf0\ulnone\fs21\par
\ul\fs22\par
\ulnone\b Dr. Varun Rajan MD (Internal Medicine), DM (Medical Oncology)\line\b0 Consultant - Medical Oncology\tab\tab\tab\tab\line Rajagiri Hospital\par
Phone no: +91 9446805593\par
E-Mail: \cf1\ul varun.rajan@rajagirihospital.com <mailto:varun.rajan@rajagirihospital.com>\cf0\ulnone\par
\pard\qj\line\b Dr. Ayesha Jaleel DMRT DNB\b0\par
\pard Consultant \tab\tab\tab\tab\line Rajagiri Hospital\par
Phone no: +91 9645884553\par
E-Mail: \cf1\ul ayesha.jaleel@rajagirihospital.com <mailto:rahul.ravind@rajagirihospital.com>\cf0\ulnone\par
 \par
\b Ms. Anooja  Jose\b0\par
Physician Assistant\par
\pard\nowidctlpar\sa200\sl276\slmult1 Rajagiri Hospital\par
\cf2\highlight3\kerning0\b\i\par
Rajagiri Telemedicine Service\b0  - Video Consult with your doctor,\lang16393  \lang1033 from the comfort of your home, using laptop/Mobile and Internet. To book a tele-consult, e-mail to\lang16393  \ul telemedicine@rajagirihospital.com\cf0\highlight0\ulnone\b\i0\f3\par
},<Age:71:Age>,<Sex:1:Sex>,
